Selenocysteine of thioredoxin reductase as the primary target for the antitumor metallodrugs: A computational point of view

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of Organometallic Chemistry

• Publication date

  2022-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jorganchem.2022.122330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Reactivity of antitumor coinage metal-based N-heterocyclic carbene complexes with cysteine and selenocysteine protein sites.

  2021cited by this paper
• Probing the Paradigm of Promiscuity for N-Heterocyclic Carbene Complexes and their Protein Adduct Formation.

  2021cited by this paper
• Anti-Inflammatory Effect of Auranofin on Palmitic Acid and LPS-Induced Inflammatory Response by Modulating TLR4 and NOX4-Mediated NF-κB Signaling Pathway in RAW264.7 Macrophages

  2021cited by this paper
• Medicinal inorganic chemistry: an updated review on the status of metallodrugs and prominent metallodrug candidates

  2021cited by this paper
• Molecular dynamics simulation of the Pb(II) coordination in biological media via cationic dummy atom models

  2021cited by this paper
• Computational strategies to model the interaction and the reactivity of biologically-relevant transition metal complexes

  2021cited by this paper
• Reaction of dirhodium and diruthenium paddlewheel tetraacetate complexes with nucleophilic protein sites: A computational study

  2021cited by this paper
• Reactivity of N-Heterocyclic Carbene Half-Sandwich Ru-, Os-, Rh-, and Ir-Based Complexes with Cysteine and Selenocysteine: A Computational Study.

  2021cited by this paper
• Thioredoxin Reductase Inhibition for Cancer Therapy.

  2021cited by this paper
• Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey

  2021cited by this paper
• Antimicrobial effect of auranofin against Acanthamoeba spp.

  2021cited by this paper
• Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis.

  2020cited by this paper
• Recent Advances of Gold Compounds in Anticancer Immunity

  2020cited by this paper
• Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.

  2020cited by this paper
• Cytotoxic Ag(I) and Au(I) NHC-carbenes bind DNA and show TrxR inhibition.

  2020cited by this paper
• Direct Observation of Methylmercury and Auranofin Binding to Selenocysteine in Thioredoxin Reductase.

  2020cited by this paper
• Insight into the Substitution Mechanism of Antitumor Au(I) N-Heterocyclic Carbene Complexes by Cysteine and Selenocysteine.

  2020cited by this paper
• Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2 Complexes.

  2020cited by this paper
• Density functional theory study of gold(III)-dithiocarbamate complexes with characteristic anticancer potentials.

  2020cited by this paper
• Gold metalation of proteins: Structural studies

  2020cited by this paper
• Reactivity of arsenoplatin complex versus water and thiocyanate: a DFT benchmark study

  2020cited by this paper
• Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study

  2020cited by this paper
• Advances in alkynyl gold complexes for use as potential anticancer agents

  2020cited by this paper
• Antibacterial and antivirulence activities of auranofin against Clostridium difficile.

  2019cited by this paper
• Insights into the Mechanisms of Aquaporin-3 Inhibition by Gold(III) Complexes: the Importance of Non-Coordinative Adduct Formation.

  2019cited by this paper
• Computational investigations of bioinorganic complexes: The case of calcium, gold and platinum ions

  2019cited by this paper
• Determinants of the Lead(II) Affinity in pbrR Protein: A Computational Study.

  2019cited by this paper
• A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppression.

  2019cited by this paper
• An Insight on the Gold(I) Affinity of golB Protein via Multilevel Computational Approaches.

  2019cited by this paper
• NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry

  2019cited by this paper
• Cyclometalated AuIII Complexes for Cysteine Arylation in Zinc Finger Protein Domains: towards Controlled Reductive Elimination

  2019cited by this paper
• Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.

  2019cited by this paper
• Potential Anticancer Activity of Auranofin.

  2019cited by this paper
• Reactivity of Gold(I) Monocarbene Complexes with Protein Targets: A Theoretical Study

  2019cited by this paper
• Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling

  2019cited by this paper
• A gold(i) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs.

  2019cited by this paper
• Insight into the Electrochemical Reduction Mechanism of Pt(IV) Anticancer Complexes.

  2018cited by this paper
• Insights on the activity of platinum-based anticancer complexes through computational methods

  2018cited by this paper
• Selenium, Selenoproteins, and Immunity

  2018cited by this paper
• Pharmacomodulation on Gold-NHC complexes for anticancer applications - is lipophilicity the key point?

  2018cited by this paper
• Reactivity of the [Au(C^N^C)Cl] complex in the presence of H2O and N-, S- and Se-containing nucleophiles: a DFT study

  2018cited by this paper
• Gold(III) Complexes for Antitumor Applications: An Overview.

  2018cited by this paper
• New insights in Au-NHCs complexes as anticancer agents.

  2018cited by this paper
• Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.

  2018cited by this paper
• Computational Chemistry: The Fate of Current Methods and Future Challenges.

  2018cited by this paper
• Synthesis and anticancer activity of novel NHC-gold(I)-sugar complexes

  2018cited by this paper
• Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug‐Resistant Pathogens: Structure–Activity Relationships

  2018cited by this paper
• Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin

  2018cited by this paper
• Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS.

  2018cited by this paper
• Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi

  2017cited by this paper
• Thioredoxin reductase inhibitors: a patent review

  2017cited by this paper
• Gold(I) complexes with aryl-thiosemicarbazones: Molecular modeling, synthesis, cytotoxicity and TrxR inhibition

  2017cited by this paper
• Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study.

  2017cited by this paper
• Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.

  2017cited by this paper
• Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.

  2016cited by this paper
• Biological and chemical interest in selenium: a brief historical account

  2016cited by this paper
• Why Nature Chose Selenium.

  2016cited by this paper
• Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs

  2016cited by this paper
• X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action.

  2016cited by this paper
• Ligand Exchange Reaction of Au(I) R-N-Heterocyclic Carbene Complexes with Cysteine.

  2016cited by this paper
• Novel antitumor adamantane–azole gold(I) complexes as potential inhibitors of thioredoxin reductase

  2016cited by this paper
• Caffeine derived platinum(II) N-heterocyclic carbene complexes with multiple anti-cancer activities

  2015cited by this paper
• Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

  2015cited by this paper
• Metallodrugs in medicinal inorganic chemistry.

  2014cited by this paper
• Selenium and selenocysteine: roles in cancer, health, and development.

  2014cited by this paper
• Reactivity of auranofin with S-, Se- and N-containing amino acids

  2014cited by this paper
• Redox active motifs in selenoproteins

  2014cited by this paper
• Why Is Mammalian Thioredoxin Reductase 1 So Dependent upon the Use of Selenium?

  2014cited by this paper
• Cytotoxic Gold(I) N‐heterocyclic Carbene Complexes with Phosphane Ligands as Potent Enzyme Inhibitors

  2014cited by this paper
• TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes

  2013cited by this paper
• Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights.

  2013cited by this paper
• Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes.

  2013cited by this paper
• A chemical-biological evaluation of rhodium(I) N-heterocyclic carbene complexes as prospective anticancer drugs.

  2013cited by this paper
• Oxaliplatin: a review of approved uses

  2012cited by this paper
• Next-generation anticancer metallodrugs.

  2012cited by this paper
• N-Heterocyclic carbene transition metal complexes for catalysis in aqueous media.

  2012cited by this paper
• Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.

  2011cited by this paper
• Differing views of the role of selenium in thioredoxin reductase

  2011cited by this paper
• Molecular mechanisms and proposed targets for selected anticancer gold compounds.

  2011cited by this paper
• Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.

  2011cited by this paper
• From Catalysts to Bioactive Organometallics: Do Grubbs Catalysts Trigger Biological Effects?

  2011cited by this paper
• Bioinorganic and medicinal chemistry: aspects of gold(I)-protein complexes.

  2011cited by this paper
• Interplay between theory and experiment: computational organometallic and transition metal chemistry.

  2010cited by this paper
• Thioredoxin and thioredoxin reductase: current research with special reference to human disease.

  2010cited by this paper
• Structural analysis of the anti-arthritic drug Auranofin: Its complexes with cysteine, selenocysteine and their fragmentation products

  2010cited by this paper
• Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.

  2010cited by this paper
• Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.

  2009cited by this paper
• DFT investigation of the interaction between gold(I) complexes and the active site of thioredoxin reductase

  2009cited by this paper
• On the medicinal chemistry of gold complexes as anticancer drugs

  2009cited by this paper
• Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.

  2008cited by this paper
• Inhibition of cathepsin B by Au(I) complexes: a kinetic and computational study

  2008cited by this paper
• The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.

  2007cited by this paper
• Non Platinum Metal Complexes as Anti‐cancer Drugs

  2007cited by this paper
• Activity of rat cytosolic thioredoxin reductase is strongly decreased by trans-[bis(2-amino-5- methylthiazole)tetrachlororuthenate(III)]: first report of relevant thioredoxin reductase inhibition for a ruthenium compound.

  2007cited by this paper
• Mechanisms of resistance to cisplatin and carboplatin.

  2007cited by this paper
• Targeting Thioredoxin Reductase 1 Reduction in Cancer Cells Inhibits Self-Sufficient Growth and DNA Replication

  2007cited by this paper
• Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.

  2006cited by this paper
• A critical evaluation of DFT, including time-dependent DFT, applied to bioinorganic chemistry

  2006cited by this paper
• Cisplatin : chemistry and biochemistry of a leading anticancer drug

  2006cited by this paper
• Human selenoproteins at a glance

  2005cited by this paper

• Synthesis and Characterization of Gold(I) N-Heterocyclic Carbenes Complexes Bearing Methacrylate Moiety

  2025cites this paper
• Substituent Effect of Superhalogens on the Metallodrug IMeAuCl: A DFT Study.

  2025cites this paper
• Multinuclear Silver(I)-Selenium Clusters Formation in Selenopeptides.

  2025cites this paper
• Au(I) complexes bearing Allyldiphenylphosphine and thiolate ligands: Synthesis, structural characterization, and biological evaluation

  2025cites this paper
• Ligand Basicity Governs Cysteine Reactivity in Au(I)–NHC Thiolate Complexes: A Computational Study

  2025cites this paper
• Metallomics Research 2022 (3)

  2023cites this paper